NYSE
CAPL
Last Price
US $22.32
KEY FIGURES
MKT CAP
$0.8B
EPS
TTM
$1.49
PEG
TTM
0.16x
P/E
TTM
14.56x
P/S
TTM
0.23x
YIELD
9.43%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
CrossAmerica Partners LP cash flow to debt ratio of 10.08% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
CrossAmerica Partners LP's free cash flow has decreased -9.27% from $61.46M last year to $55.77M, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
CrossAmerica Partners LP's debt to equity ratio is -10.80, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Healthy debt to equity ratio development.
CrossAmerica Partners LP's debt to equity ratio is -10.80, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Net debt/EBITDA.
CrossAmerica Partners LP has a net debt to EBITDA ratio of 4.82x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
CrossAmerica Partners LP's interest coverage ratio of 5.36 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
CrossAmerica Partners LP's profit margin has increased (221.81%) in the last year from 0.49% to 1.56%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
CrossAmerica Partners LP's short-term liabilities of $155.22M exceed its short-term assets of $111.08M, signaling financial risk
Increasing performance - ROA.
CrossAmerica Partners LP's return on assets of 5.67% is higher than the 5.00% threshold, indicating efficient asset utilization
Decreasing performance - Absolute return on equity.
CrossAmerica Partners LP's return on equity of -85.35%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
CrossAmerica Partners LP's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
CrossAmerica Partners LP had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
CrossAmerica Partners LP has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
CrossAmerica Partners LP has a free cash flow yield of 6.56%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
CrossAmerica Partners LP's yearly earnings has increased 110.30% since last year from $19.89M to $41.83M, signaling increasing performance
Decreasing performance - Healthy revenue growth.
CrossAmerica Partners LP's yearly revenue has decreased -10.63% since last year from $4.10G to $3.66G, signaling decreasing performance
Increasing performance - ROIC.
ROIC 13.11% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Decreasing performance - 3-year revenue CAGR.
CrossAmerica Partners LP's 3-year revenue CAGR of -9.66% is negative, indicating declining revenue over the past 3 years
Decreasing performance - Revenue consistency.
CrossAmerica Partners LP had revenue growth in only 2.00 out of 5 years, indicating inconsistent revenue performance
Increasing performance - ROE consistency.
CrossAmerica Partners LP had positive ROE in 3.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
CrossAmerica Partners LP has insufficient data to evaluate this check.
Undervalued - Earnings yield.
CrossAmerica Partners LP has an earnings yield of 6.70%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
CrossAmerica Partners LP is overvalued relative to its fair value price of 10.75 based on EBITDA multiple model
Undervalued - EV/EBITDA.
CrossAmerica Partners LP has an EV/EBITDA ratio of 8.75x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
CrossAmerica Partners LP has a PEG-ratio under 1 which is considered undervalued
Overvalued - P/B ratio.
CrossAmerica Partners LP has negative shareholder equity; price-to-book is not meaningful and the check fails
Undervalued - P/S ratio.
CrossAmerica Partners LP has a price-to-sales ratio of 0.23x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-85.35%
Return on equity
ROIC: 13.11%
Valuation History
14.6X
Price to Earnings
EV/EBITDA: 8.8X
Cash flow
Profit margin
13.64%
(FY vs FY)
EBITDA Y/Y
0.32%
(FY vs FY)
Cash flow Y/Y
-3.73%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $22.32
—
Default assumptions
EBITDA Multiple
Fair Value
Market $22.32
-51.84%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.